Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Metrolyl 1g suppositories
0501110C0BFAEAH
|
Metrolyl | Metronidazole | Infections | No data available |
|
Metrolyl 500mg suppositories
0501110C0BFADAG
|
Metrolyl | Metronidazole | Infections | No data available |
|
Metronidazole 0.8% gel
1310012K0AAAQAQ
|
Metronidazole (Topical) | Metronidazole | Skin | No data available |
|
Metronidazole 0.85% gel
1310012K0AABHBH
|
Metronidazole (Topical) | Metronidazole | Skin | No data available |
|
Metronidazole 10% ointment
1310012K0AABIBI
|
Metronidazole (Topical) | Metronidazole | Skin | No data available |
|
Metronidazole 100mg/20ml solution for infusion ampoules
0501110C0AAADAD
|
Metronidazole (Systemic) | Metronidazole | Infections | No data available |
|
Metronidazole 100mg/5ml oral liquid
0501110C0AABLBL
|
Metronidazole (Systemic) | Metronidazole | Infections | No data available |
|
Metronidazole 2% cream
1310012K0AAAEAE
|
Metronidazole (Topical) | Metronidazole | Skin | No data available |
|
Metronidazole 200mg suppositories
0501110C0AABJBJ
|
Metronidazole (Systemic) | Metronidazole | Infections | No data available |
|
Metronidazole 25% oromucosal gel sugar free
1203020J0AAAAAA
|
Metronidazole (Mouthwash) | Metronidazole | Ear, Nose and Oropharynx | No data available |
|
Metronidazole 400mg tab and Nystatin 100,000unit pess
0501110C0AAA8A8
|
Metronidazole (Systemic) | Metronidazole | Infections | No data available |
|
Metronidazole 500mg/100ml solution for infusion bottles
0501110C0AAAKAK
|
Metronidazole (Systemic) | Metronidazole | Infections | No data available |
|
Metronidazole 500mg/5ml oral suspension
0501110C0AABSBS
|
Metronidazole (Systemic) | Metronidazole | Infections | No data available |
|
Metronidazole 50mg/5ml oral liquid
0501110C0AABRBR
|
Metronidazole (Systemic) | Metronidazole | Infections | No data available |
|
Metronidazole 50mg/5ml oral suspension
0501110C0AABUBU
|
Metronidazole (Systemic) | Metronidazole | Infections | No data available |
|
Metrozol 500mg/100ml infusion 100ml bags
0501110C0BQAABA
|
Metrozol | Metronidazole | Infections | No data available |
|
Metsol 500mg/5ml oral solution
0601022B0BHAAAR
|
Metsol | Metformin hydrochloride | Endocrine System | No data available |
|
Metvix 16% cream
1308010X0BBAAAA
|
Metvix | Methyl-5-aminolevulinate | Skin | No data available |
|
Mevalia low protein anellini
0913261K0BDAEAC
|
Mevalia specialist food replacer pasta | Specialist food replacer pasta (0913261) | Nutrition and Blood | No data available |
|
Mevalia low protein cake mix
0913451B0BBAAAA
|
Mevalia food replacer discontinued or OTC cake mix | Food replacer discontinued or OTC cake mix (0913451) | Nutrition and Blood | No data available |
|
Mevalia low protein crostini
0904010F0BGACAA
|
Mevalia (Gluten free low protein bread) | Gluten free/low protein bread | Nutrition and Blood | No data available |
|
Mevalia low protein fette biscottate
0904010X0BJAAAA
|
Mevalia (Low protein bread) | Low protein breads | Nutrition and Blood | No data available |
|
Mevalia low protein magdalenas
0913451A0BBAAAA
|
Mevalia food replacer discontinued or OTC cakes | Food replacer discontinued or OTC cakes (0913451) | Nutrition and Blood | No data available |
|
Mevalia low protein pasta rigatoni
0913261K0BDAFAC
|
Mevalia specialist food replacer pasta | Specialist food replacer pasta (0913261) | Nutrition and Blood | No data available |
|
Mevalia PKU GMPower oral powder 10g sachets
0913621A0BBAAAA
|
Mevalia powder 10g GMP protein equivalent | Powder 10g GMP protein equivalent (0913621) | Nutrition and Blood | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.